Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorSan Diego State University

About this trial

The objective of this study is to examine if calcium and vitamin D supplements and/or prune can prevent bone loss in postmenopausal women.

Eligibility criteria

Qualifiers

Postmenopausal

BMD t-score is between 0.5 and 2 SD below the mean

Not on hormone replacement therapy (HRT) and/or other pharmacological agents known to affect bone for at least three months prior to initiation of the study

Disqualifiers

Women whose BMD t-score at any site falls below 2.5 SD of the mean

Subjects receiving endocrine (e.g., prednisone, other glucocorticoids) or neuroactive (e.g., dilantin, phenobarbital) drugs or any drugs known to influence bone and calcium metabolism

Subjects who smoke cigarettes or vape

Regular consumption of dried plum or prune juice

Trial design

Treatments tested in this trial

  • Prune

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators